Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Idiopathic intracranial hypertension
ADR ID BADD_A10096
ADR Hierarchy
17      Nervous system disorders
17.07      Increased intracranial pressure and hydrocephalus
17.07.02      Increased intracranial pressure disorders
17.07.02.011      Idiopathic intracranial hypertension
Description A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS). [MeSH]
MedDRA Code 10078904
MeSH ID D011559
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Benign intracranial hypertension | Intracranial pressure inc. benign | Pseudotumor cerebri | Intracranial pressure increased benign | Pseudotumour cerebri | Idiopathic intracranial hypertension | Pseudotumor Cerebri | Idiopathic Intracranial Hypertension | Hypertension, Idiopathic Intracranial | Intracranial Hypertension, Idiopathic | Benign Intracranial Hypertension | Hypertension, Benign Intracranial | Intracranial Hypertension, Benign
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01951Risperidone0.000606%
BADD_D01959Rocuronium0.000057%
BADD_D01966Ropinirole--
BADD_D02010Sertraline0.000045%
BADD_D02066Spironolactone0.000037%
BADD_D02093Sulfasalazine0.000455%
BADD_D02105Tacrolimus0.001040%
BADD_D02171Testosterone cypionate0.011533%
BADD_D02174Testosterone undecanoate-
BADD_D02217Tigecycline--
BADD_D02247Topiramate0.000075%
BADD_D02270Tretinoin0.001067%
BADD_D02271Triamcinolone--
BADD_D02272Triamcinolone acetonide--
BADD_D02440Lisdexamfetamine0.000070%
BADD_D02473Sodium chloride--
BADD_D02492Deflazacort0.000034%
The 3th Page    First    Pre   3    Total 3 Pages